Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-07 Sale | 2023-03-09 4:39 pm | Rallybio Corp | RLYB | PARMAR KUSH Director | 100,000 | $8.2 | $820,000 | 3,630,724 (Indirect) | View |
| 2022-08-15 Purchase | 2022-08-17 8:01 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 10% Owner | 600,000 | $30 | $18,000,000 | 983,656 (Indirect) | View |
| 2022-06-03 Sale | 2022-06-07 5:03 pm | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 150,000 | $12.5 | $1,875,000 | 1,251,755 (Indirect) | View |
| 2022-05-23 Sale | 2022-05-25 6:34 pm | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 100,000 | $13 | $1,300,000 | 1,302,084 (Indirect) | View |
| 2022-02-08 Sale | 2022-02-10 6:22 pm | Rallybio Corp | RLYB | PARMAR KUSH Director | 210,000 | $13.05 | $2,740,500 | 1,335,637 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:45 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 470,000 | $16 | $7,520,000 | 496,323 (Indirect) | View |
| 2021-11-16 Sale | 2021-11-18 8:10 pm | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 330,706 | $15.3 | $5,059,802 | 1,766,634 (Indirect) | View |
| 2021-11-02 Purchase | 2021-11-05 08:49 am | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) | View |
| 2021-11-01 Sale | 2021-11-03 4:38 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 295,000 | $13 | $3,835,000 | 333,144 (Indirect) | View |
| 2021-09-07 Sale | 2021-09-09 5:34 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 625,000 | $9.7 | $6,062,500 | 2,359,263 (Indirect) | View |
| 2021-08-02 Purchase | 2021-08-04 9:19 pm | Rallybio Corp | RLYB | PARMAR KUSH Director | 615,384 | $13 | $7,999,992 | 4,994,878 (Indirect Direct) | View |
| 2021-04-27 Purchase | 2021-04-29 8:51 pm | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 575,000 | $15 | $8,625,000 | 575,000 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 5:15 pm | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 555,555 | $18 | $9,999,990 | 1,875,370 (Indirect Direct) | View |
| 2021-01-08 Sale | 2021-01-12 5:07 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 387,000 | $13 | $5,031,000 | 369,688 (Indirect) | View |
| 2020-12-29 Sale | 2020-12-31 9:32 pm | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 470,000 | $18 | $8,460,000 | 982,453 (Indirect) | View |
| 2020-12-22 Sale | 2020-12-28 9:37 pm | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 500,000 | $12.82 | $6,410,000 | 181,435 (Indirect) | View |
| 2020-12-14 Sale | 2020-12-16 7:25 pm | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 500,000 | $12.25 | $6,125,915 | 201,435 (Indirect) | View |
| 2020-12-10 Sale | 2020-12-14 5:58 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 298,000 | $14.75 | $4,395,500 | 417,629 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-03-06 5:18 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH 10% Owner | 0 | $0 | 5,798,475 (Indirect) | View |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |
| 2023-01-03 Option Award | 2023-01-05 6:29 pm | N/A 2033-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 10,344 | $0 | 10,344 (Direct) | View |
| 2022-11-30 Equity Swap | 2022-12-02 4:49 pm | N/A N/A | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 4,135,786 | $0 | 0 (Indirect) | View |
| 2022-12-01 Disposition | 2022-12-02 4:49 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 0 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:02 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:05 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:09 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 16,911 | $0 | 16,911 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:01 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 11,918 | $0 | 11,918 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 8:08 pm | N/A 2032-05-24 | Rallybio Corp | RLYB | PARMAR KUSH Director | 13,440 | $0 | 13,440 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:45 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 17,017,645 | $0 | 496,323 (Indirect) | View |
Ownership | 2022-01-06 9:02 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 0 | $0 | 3,867,646 (Indirect) | View |
| 2022-01-03 Option Award | 2022-01-05 8:38 pm | N/A 2032-01-03 | Rallybio Corp | RLYB | PARMAR KUSH Director | 5,772 | $0 | 5,772 (Direct) | View |
| 2021-11-02 Conversion | 2021-11-05 08:49 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 3,827,224 | $0 | 1,132,357 (Indirect) | View |
Ownership(A) | 2021-11-05 08:48 am | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 0 | $0 | 2,371,739 (Indirect) | View |
| 2021-10-28 Option Award | 2021-11-01 9:48 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 23,552 | $0 | 23,552 (Direct) | View |
Ownership | 2021-10-28 9:57 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 0 | $0 | 4,158,379 (Indirect) | View |
| 2021-07-28 Other | 2021-08-04 9:19 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director | 26,341,690 | $0 | 4,994,878 (Indirect) | View |
| 2021-07-28 Option Award | 2021-08-04 9:19 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director | 13,440 | $0 | 4,994,878 (Direct) | View |
Ownership | 2021-07-29 7:38 pm | N/A N/A | Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner | 0 | $0 | 3,588,780 (Indirect) | View |
| 2021-06-24 Option Award | 2021-06-25 4:38 pm | N/A 2031-06-23 | Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:40 pm | N/A 2031-06-17 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-29 8:51 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 39,725,924 | $0 | 575,000 (Indirect) | View |
| 2021-04-27 Conversion | 2021-04-29 8:51 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 101,457 | $13.5 | 575,000 (Indirect) | View |
| 2021-04-22 Other | 2021-04-26 5:55 pm | N/A 2021-12-31 | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 1,359,799 | $0 | 1,359,799 (Indirect) | View |
Ownership | 2021-04-22 8:04 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 0 | $0 | 2,208,334 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 5:15 pm | N/A N/A | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 88,184,384 | $0 | 1,875,370 (Indirect) | View |
| 2021-02-05 Option Award | 2021-02-09 5:15 pm | N/A 2031-02-04 | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 16,900 | $0 | 1,875,370 (Direct) | View |
Ownership | 2021-02-04 9:49 pm | N/A N/A | Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner | 0 | $0 | 6,136,874 (Indirect) | View |
| 2020-11-30 Other | 2020-12-01 5:42 pm | N/A N/A | 5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner | 235,932 | $0 | 1,944,068 (Indirect) | View |
| 2020-11-17 Other | 2020-11-18 4:31 pm | N/A N/A | 5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner | 30,000 | $0 | 2,180,000 (Indirect) | View |